Introduction
Sarcoidosis is a systemic granulomatous disease of unknown etiology that
most commonly affects the lungs and lymph nodes but can involve nearly
any organ. When the central nervous system is affected, a condition
known as neurosarcoidosis [1], it often presents with cranial
neuropathies [2]. Among its less common but severe complications,
acute ischemic stroke can occur due to mechanisms such as granulomatous
vasculitis, vascular compression, or systemic hypercoagulability
[3]. The overlap of symptoms with other neurological conditions,
combined with its rarity, makes diagnosing stroke in neurosarcoidosis
particularly challenging. Early identification and targeted treatment
are crucial to minimizing long-term disability.